Common Contracts
3 similar Underwriting Agreement contracts by Advaxis, Inc., Elicio Therapeutics, Inc., OptiNose, Inc.
ELICIO THERAPEUTICS, INC. 500,000 SHARES OF COMMON STOCK (PAR VALUE $0.01) WARRANTS TO PURCHASE 2,300,000 SHARES OF COMMON STOCK PRE-FUNDED WARRANTS TO PURCHASE 1,800,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • July 1st, 2024 • Elicio Therapeutics, Inc. • Pharmaceutical preparations • New York
26,320,000 Shares of Common Stock and Warrants to Purchase 26,320,000 Shares of Common Stock OptiNose, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • November 23rd, 2022 • OptiNose, Inc. • Pharmaceutical preparations • New York
OptiNose, Inc., a Delaware corporation (the “Company”), proposes to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of (i) 26,320,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company and (ii) 26,320,000 common stock warrants to purchase 26,320,000 shares of Common Stock (the “Common Warrants” and, together with the Firm Shares, the “Firm Securities”). The amount and form of the Firm Securities to be purchased by each Underwriter is set forth on Schedule I hereto. The Company has also granted to the Underwriters an option to purchase up to 3,948,000 additional shares of Common Stock (the “Option Shares”) and/or 3,948,000 additional Common Warrants to purchase up to 3,948,000 shares of Common Stock (the “Option Warrants” and, together with the Option Shares, the “Option Securities” and together with the Firm Securities, the “Securities”), each on the terms and for the purposes set forth in Se
16,666,666 Shares of Common Stock and Warrants to Purchase up to 14,166,666 Shares of Common Stock Advaxis, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • September 11th, 2018 • Advaxis, Inc. • Pharmaceutical preparations • New York
